Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

Fig. 3

Longitudinal changes in cholesterol values. a Longitudinal LDL-C values before and after 12, and 52 weeks of treatments: Blue lines indicates DST therapy while orange lines indicate DST therapy. Error bars represent standard deviations. Asterisks indicate statistically significant difference between groups by Wilcoxon tests. b Longitudinal TC values before and after 12, and 52 weeks of treatments: Blue lines indicates DST therapy while orange lines indicate DST therapy. Error bars represent standard deviations. Asterisks indicate statistically significant difference between groups by Wilcoxon tests. c Longitudinal sdLDL-C values before and after 12, and 52 weeks of treatments: Blue lines indicates DST therapy while orange lines indicate DST therapy. Error bars represent standard deviations. Asterisks indicate statistically significant difference between groups by Wilcoxon tests

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X